Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 52.56 |
| Open | 50.40 |
| Bid | 52.05 x 300 |
| Ask | 52.15 x 300 |
| Day's range | 50.35 - 53.76 |
| 52-week range | 50.27 - 69.83 |
| Volume | |
| Avg. volume | 1,847,373 |
| Market cap | 11.687B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 15.77 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
WILMINGTON, Del., April 30, 2024--Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
- Business Wire
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
WILMINGTON, Del. & SAN DIEGO, April 23, 2024--Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
- Business Wire
Incyte to Report First Quarter Financial Results
WILMINGTON, Del., April 11, 2024--Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, April 30, 2024.
© 2024 Yahoo. All rights reserved.